`
`Paper No. 40
`Date Filed: June 26, 2018
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________
`
`BEFORE THE PATENT AND TRIAL APPEAL BOARD
`____________________________
`
`OTICON MEDICAL AB; OTICON MEDICAL LLC;
`WILLIAM DEMANT HOLDING A/S,
`
`Petitioner
`
`v.
`
`COCHLEAR BONE ANCHORED SOLUTIONS AB
`
`Patent Owner
`____________________________
`
`Case No. IPR2017-010181
`U.S. Patent No. 7,043,040 B2
`____________________________
`
`
`PETITIONER'S REPLY TO PATENT OWNER'S SUPPLEMENTAL
`RESPONSE ADDRESSING CLAIMS 7-10
`
`
`1 Case No. IPR2017-01019 has been consolidated with the instant proceeding. To
`avoid confusion, certain papers are cited herein using Number "-01018" (e.g.,
`"-01018 Pet.") to distinguish from papers associated with IPR2017-01019.
`
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`
`TABLE OF CONTENTS
`
`IV.
`
`TABLE OF AUTHORITIES .................................................................................... ii
`I.
`Argument Summary ........................................................................... 1
`II.
`Claim Construction Issues ................................................................. 1
`III.
`Claims 7, 9 - Unpatentable over Vaneecloo, Carlsson and Leysieffer
` ........................................................................................................... 2
`Claim 8 - Unpatentable Over Vaneecloo, Carlsson, Leysieffer,
`Schaefer ............................................................................................. 5
`Claim 10 - Unpatentable over Vaneecloo, Carlsson, Leysieffer,
`Lesinski ............................................................................................. 6
`Conclusion ......................................................................................... 7
`VI.
`CERTIFICATE OF PAGE COUNT .......................................................................... 8
`
`
`V.
`
`i
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`
`TABLE OF AUTHORITIES
`
`Cases
`In re Keller, 642 F.2d 413 (CCPA 1981) .................................................................. 6
`In re Merck & Co., Inc., 800 F.2d 1091 (Fed. Cir. 1986) .......................................... 6
`In re Mouttet, 686 F.3d 1322 (Fed. Cir. 2012) .......................................................... 7
`KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398 (2007) ................................................... 3
`Tokai Corp. v. Easton Enters., 632 F.3d 1358 (Fed. Cir. 2011) ................................ 7
`
`ii
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`I.
`
`Argument Summary
`
`
`
`Patent Owner's Supplemental Response ("Supp. Resp.") does not dispute
`
`that claims 7-10 broadly recite aspects of hearing aid technology that were well
`
`known prior to the critical date. Indeed, the broad language of claims 7-10 no more
`
`than mirrors a single sentence of the '040 patent description, which provides no
`
`technical detail whatsoever. Any attempt to practice claims 7-10 would, at best,
`
`rely entirely on teachings of the prior art and knowledge in the public domain.
`
`Patent Owner attempts to distract from the straight-forward combinations of the
`
`instituted grounds by mischaracterizing the state of the art and by engaging in
`
`obviousness analysis that is contrary to law.
`
`II. Claim Construction Issues
`
`Patent Owner offers these constructions: "digital signal processing means"
`
`(claim 7) – as meaning "a digital signal processor"; "the signal processing means
`
`adapts frequency characteristics" (claim 8) – meaning the "digital signal processing
`
`means" of claim 7, with the rest of the claim being interpreted in accordance with
`
`its ordinary meaning; "signal processing means for actively counteracting acoustic
`
`feed-back problems in the apparatus" (claim 9) – meaning "a digital signal
`
`processor configured to actively counteract acoustic feedback problems in the
`
`apparatus"; and "directivity means" (claim 10) – meaning "a directivity dependent
`
`microphone and/or digital signal processor." Supp. Resp. at 3-5.
`
`1
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`
`For purposes of this IPR proceeding only, and without waiver of its right to
`
`argue for indefiniteness in district court, Petitioner respectfully submits that the
`
`Board can and should properly address the instituted grounds for claims 7-10 based
`
`on Patent Owner's broad constructions.
`
`III. Claims 7, 9 - Unpatentable over Vaneecloo, Carlsson and Leysieffer
`
`Claim 7 recites: "… wherein the electronic circuitry [or claim 6] comprises
`
`digital signal processing means." With respect to claim 6, the Board recognized
`
`that "modifying the BAHA device of Vaneecloo and Carlsson to include an
`
`analog-to-digital converter as taught by Leysieffer would have been obvious to a
`
`skilled artisan, inter alia, to obtain advantages associated with digital
`
`processing…." See -01018 Inst. Dec'n at 25 (emphasis added). This conclusion is
`
`fully supported by the record and clearly extends to the "digital signal processing
`
`means" broadly recited in claim 7. The '040 patent fails to disclose any specific
`
`DSP circuitry, and both experts in this case have acknowledged that benefits of
`
`digital processing in hearing aid devices were known prior to the critical date. Ex.
`
`1121, 49:8-51:5, 57:23-58:18, 60:16-21; Ex. 1002, ¶¶ 155-156, 158-162, 164.
`
`Nonetheless, Patent Owner illogically asserts that a POSA would not "have
`
`been motivated to modify [a BAHA] to include a DSP because there would be no
`
`reason to do so." Supp. Resp. at 5-6. Patent Owner more specifically alleges that
`
`including a DSP in a BAHA would only be beneficial "(1) if sending sound
`
`2
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`vibrations to the auditory nerve of an injured cochlea like air conduction hearing
`
`aids do, (2) if addressing feedback which is a frequent problem in air conduction
`
`hearing aids, and (3) if addressing the effects of a patient's skull characteristics
`
`(transcranial attenuation "TA") as identified in the '040 patent." Supp. Resp. at 6-8.
`
`Patent Owner's argument is fatally flawed for several reasons.
`
`First, Patent's Owner's argument is at odds with the broad scope of claim 7.
`
`Under proper obviousness analysis, "neither the particular motivation nor the
`
`avowed purpose of the patentee controls." Instead, "[w]hat matters is the objective
`
`reach of the claim." KSR Int'l Co. v. Teleflex Inc., 550 U.S. 398, 419 (2007).
`
`Second, Patent Owner's argument that a DSP could only be beneficial in the three
`
`identified instances is incorrect. The benefits of digital signal processing in
`
`general, and in hearing aids specifically, were well known and previously
`
`acknowledged by both Dr. Popelka and Dr. Rubenstein. Ex. 1121, 49:8-51:5,
`
`57:23-58:18, 60:16-21; Ex. 1002, ¶¶ 155-156, 158-162, 164. Benefits of
`
`incorporating a DSP in hearing aid devices have been recognized since at least the
`
`mid 1980's (Ex. 1129, generally including 3:3-19), and major hearing aid
`
`manufacturers had already begun selling digital hearings aids before the critical
`
`date. See Ex. 1128, noting that "[t]he concept of digital signal processing (DSP)
`
`instruments is no longer novel or surprising to dispensers or consumers" correctly
`
`predicting that "digital hearing aids will be the standard fitting" (Ex. 1128-001),
`
`3
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`and identifying numerous benefits associated with digital hearing aids, including
`
`programmability, precise fitting, effective feed-back cancellation, noise
`
`suppression, program selection for different sound environments, and, ultimately,
`
`"increased patient benefit and satisfaction." Ex. 1128-003 to -006.
`
`With reference to claim 9, Patent Owner further argues that it would not
`
`have been obvious to modify a BAHA to include a DSP to actively counteract
`
`acoustic feedback because "such feedback was not typically a problem at the
`
`critical date" and that feedback "had already been solved prior to the critical date."
`
`Supp. Resp. at 8 (emphasis added). First, the '040 patent does not provide any
`
`detail for DSP-implemented feedback cancellation, instead relying entirely on
`
`technology in the public domain. Ex. 1127, 47:11-49:21. There were no
`
`unexpected benefits associated with incorporating active feedback cancellation in a
`
`BAHA. Id.at 49:17-21. Patent Owner's argument that acoustic feedback issues
`
`"had already been solved" is inconsistent with the earlier qualified assertion that
`
`feedback was not "typically" a problem, and this entire argument is undercut by
`
`Dr. Rubenstein's cross-examination testimony - showing that: (1) the overall gain
`
`("output") of the HC-2002 BAHA in Carlsson was limited due to acoustic feedback
`
`concerns ("stability" and design trade-off with overall gain) (Ex. 1007-051; Ex.
`
`1127, 19:7-20:25, 25:7-25, 27:12-28:1); (2) this limited output was not loud
`
`2 Also referred to as the "Classic 300." Ex. 1127, 15:7-11.
`
`4
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`enough for some patients and rendered the device unsuitable for other potential
`
`patients (limited "patient uptake") – this was recognized as "a real issue" for the
`
`BAHA (Ex. 1127, 22:23-23:24); and (3) it would have been desirable to increase
`
`overall gain while avoiding acoustic feedback (Ex. 1127, 17:8-13, 29:3-25). Thus,
`
`feedback was a major design constraint affecting BAHA performance. A POSA
`
`would have had reasons to incorporate active feedback cancellation in a BAHA.
`
`See -01018 Pet. at 50-52; Ex. 1002, ¶¶ 161-164; see also Ex. 1130 (describing
`
`DSP-implemented feedback cancellation in hearing aids early as 1992); Ex. 1128-
`
`006 (describing increased gain margins of 10 to 15 dB using active feedback
`
`cancellation).
`
`IV. Claim 8 - Unpatentable Over Vaneecloo, Carlsson, Leysieffer, Schaefer
`
`Claim 8 further recites: "… wherein the signal processing means adapts
`
`frequency characteristics to the individual differences in an acoustic head shadow
`
`effect, to a sound environment, to a resonance patient's skull, or to a hearing
`
`capacity of a functioning ear of the patient." Patent Owner alleges that there is a
`
`lack of "motivation" to combine Schaefer with Vaneecloo-Carlsson-Leysieffer
`
`because "[a]t best, Schaefer describes shaping the "frequency response" to the
`
`impaired ipsilateral ear - which is not the same as the requirement of claim 8."
`
`Supp. Resp. at 10. First, Patent Owner's argument is simply an attack on the
`
`individual Schaefer reference and fails to address the combination of the instituted
`
`5
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`grounds – where the primary reference, Vaneecloo, teaches using a bone-anchored
`
`hearing device that transmits sound from the patient's deaf side to the patient's
`
`functioning ear on the contra-lateral side. Ex. 1002, ¶¶ 68-71, 90, 91. Patent Owner
`
`cannot show nonobviousness by attacking references individually where the
`
`ground of unpatentability is based on an obvious combination of references. In re
`
`Keller, 642 F.2d 413 (CCPA 1981); In re Merck & Co., Inc., 800 F.2d 1091 (Fed.
`
`Cir. 1986). The '040 patent does not describe any detail for adapting frequency
`
`characteristics to the hearing capacity of the patient's functioning ear, instead
`
`relying entirely on technology in the public domain. Ex. 1127, 51:16-52:4. There
`
`were no unexpected benefits associated with incorporating such a known feature in
`
`a BAHA. See e.g., Id. at 52:6-12; See also -01018 Pet. at 52-55, Ex. 1002, ¶¶ 118,
`
`168-171; Ex. 2008, 103:6-104:24.
`
`V. Claim 10 - Unpatentable over Vaneecloo, Carlsson, Leysieffer, Lesinski
`
`Regarding the "directivity" feature of claim 10, the '040 patent does not
`
`detail any specific DSP "directivity means" and does not even mention a
`
`directional microphone in the alleged "detailed description," instead relying
`
`entirely on technology in the public domain. There were no unexpected benefits
`
`associated with incorporating "directivity" in a BAHA. See e.g., Ex. 1127, 43:2-10,
`
`44:12-16, 44:24-45:3; Ex. 1002, ¶¶ 176-182. Patent Owner's argument at page 11
`
`that modifying the BAHA of the Vaneecloo-Carlsson-Leysieffer combination to
`
`6
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`include a directional microphone of Lesinski would be a "fundamental change" is
`
`merely an argument of "physical combinability," which is not the proper standard
`
`for determining obviousness. In re Mouttet, 686 F.3d 1322, 1332 (Fed. Cir. 2012)
`
`(noting that "[i]t is well established that a determination of obviousness from
`
`multiple references does not require an actual, physical substitution of elements.").
`
`Moreover, Patent Owner's assertion that incorporating a directional microphone,
`
`such as disclosed in Lesinski, would be a "fundamental change" cannot be
`
`reconciled with earlier disclosure of incorporating a directional microphone in a
`
`bone-anchored hearing device. See, e.g., Ex. 1131, including 1131-004. Finally,
`
`Patent Owner's alleged "objective evidence of non-obviousness" at page 12 is
`
`entirely unsupported and cannot possibly overcome the strong prima facie showing
`
`of obviousness. Tokai Corp. v. Easton Enters., 632 F.3d 1358, 1371 (Fed. Cir.
`
`2011).
`
`VI. Conclusion
`
`Based at least on the foregoing, Petitioner respectfully requests that claims
`
`7-10 of the '040 patent be deemed unpatentable and canceled.
`
`Dated: June 26, 2018 Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/D. Richard Anderson/
`D. Richard Anderson (Reg. No. 40,439)
`Eugene T. Perez (Reg. No. 48,501)
`BIRCH, STEWART, KOLASCH & BIRCH, LLP
`
`
`7
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`
`CERTIFICATE OF PAGE COUNT
`
`
`
`
`Pursuant to the Board's Order of May 8, 2018 (Paper 33), Petitioner hereby
`
`certifies that this Reply to Patent Owner's Supplemental Response is seven (7)
`
`pages. This page count excludes the table of contents, table of authorities,
`
`certificate of page count, and certificate of service.
`
`
`
`Dated: June 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/D. Richard Anderson/
`D. Richard Anderson, Reg. No. 40,439
`Eugene T. Perez, Reg. No. 48,501
`BIRCH, STEWART, KOLASCH & BIRCH, LLP
`8110 Gatehouse Road, Suite 100E
`Falls Church, VA 22042
`Tel.: (703) 205-8000
`Fax: (703) 205-8050
`Email: mailroom@bskb.com
`Attorneys for Petitioner
`
`8
`
`
`
`IPR2017-01018 - Petitioner's Reply to Supplemental Response
`U.S. Patent No. 7,043,040
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on this 26th day of June, 2018, a copy of the foregoing
`
`PETITIONER'S REPLY TO PATENT OWNER'S SUPPLEMENTAL
`
`RESPONSE was served upon the following persons via email:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Bruce G. Chapman
`Laura M. Burson
`SHEPPARD, MULLIN, RICHTER & HAMPTON LLP
`333 South Hope Street
`43rd Floor
`Los Angeles, CA 90071-1422
`bchapman@sheppardmullin.com
`lburson@sheppardmullin.com
`
`
`
`
`
`
`
`/D. Richard Anderson/
`D. Richard Anderson
`
`
`
`